1734PDAnti-CTGF human recombinant monoclonal antibody pamrevlumab increases resectability and resection rate when combined with gemcitabine/Nab-paclitaxel in the treatment of locally advanced pancreatic cancer patients
Carrier, E., Picozzi, V., Pishvaian, M.J., Mody, K., Winter, J., Glaspy, J., Larson, T., Conway, W.C., Lipson, K., Porter, S., Kouchakji, E.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx369.166
Date:
September, 2017
File:
PDF, 49 KB
english, 2017